HF
LPCN icon

HRT Financial’s Lipocine LPCN Stock Holding History

HRT Financial’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74K Buy
+29,238
New +$70.3K ﹤0.01% 3687
2022
Q1 		– Sell
-1,422
Closed -$23K – 3519
2021
Q4 		$23K Buy
+1,422
New +$26.4K ﹤0.01% 2934
2021
Q2 		– Sell
-853
Closed -$21K – 3226
2021
Q1 		$21K Buy
+853
New +$24.6K ﹤0.01% 2595

Other funds holding LPCN

SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HRT Financial's LPCN Position: Q2 2026 in Review

HRT Financial opened a new position in Lipocine (LPCN) in Q2 2026: 29,238 shares worth $74K. The stake represents ﹤0.01% of the portfolio and ranks #3687 among its holdings. This is a return to the name: HRT Financial previously reported a position in LPCN as recently as Q4 2021.

HRT Financial first reported a position in LPCN in Q1 2021 and has held it in 3 quarters since. 36 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

  • HRT Financial held 29,238 shares of Lipocine worth $74K as of Q2 2026.
  • Lipocine was a new HRT Financial position in Q2 2026.
  • Lipocine made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3687 holding.
  • HRT Financial first reported a position in Lipocine in Q1 2021 and has held it in 3 quarters since.
  • 36 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.